Debates about cervical screening: An historical overview

Journal of Epidemiology and Community Health

Volumn 62, Issue 4, 2008, Pages 284-287

  Bryder, L ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CYTOLOGY; MORTALITY; SMOKING; SOCIAL HISTORY;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYSTERECTOMY; INCIDENCE; MEDICAL RESEARCH; MEDICAL SOCIETY; MORTALITY; PAPANICOLAOU TEST; REVIEW; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ATTITUDE OF HEALTH PERSONNEL; CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; COST-BENEFIT ANALYSIS; FEMALE; HISTORY, 20TH CENTURY; HUMANS; MASS SCREENING; PATIENT SELECTION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 41149131697     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2006.059246     Document Type: Review

References (50)

1. ICRF Coordinating Committee on Cervical Screening. Organisation of a programme for cervical cancer screening. BMJ 1984;289:894-5.
2. Cochrane AL, Holland WW. Validation of screening procedures. Br Med Bull 1971;27:3-8.
3. Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: The Nuffield Hospitals Trust, 1972:26-7, 36
4. Lund CJ. An epitaph for cervical carcinoma. JAMA 1961;175:98-9.
5. Lerner BH. The breast cancer wars: fear, hope and the pursuit of a cure in twentieth-century America. Oxford: Oxford University Press 2001:5, 29, 30, 51
6. Ross WS. Crusade: the official history of the American Cancer Society. New York: Arbor House, 1987:76, 86
7. Papanicolaou GN, Traut HF. Diagnosis of uterine cancer by vaginal smear. Oxford: Commonwealth Fund, Oxford University, 1943.
8. Casper MJ, Clarke AE. Making the Pap smear into the "right tool" for the job: cervical cancer screening in the USA, circa 1940-95. Soc Stud Sci 1998;28:255-90.
9. Boyes DA, Fidler HK, Lock DR. Significance of in situ carcinoma of the uterine cervix. BMJ 1962;1:203-5.
10. McLaren HC. The prevention of cervical cancer. London: The English Universities Press, 1963:3, 96
11. Grant MPS. Cytology in prevention of cancer of cervix. BMJ 1962;1:1637-40.
12. Cervical Cancer Prevention Campaign. 23 February 1965, SA/NWF/F13, 56. London: Wellcome Library.
13. McKelvey JL. Carcinoma in situ of the cervix: a general consideration. Am J Obstet Gynecol 1952;64:816-32.
14. Coppleson M, Reid B. Preclinical carcinoma of the cervix uteri: its nature, origin and management. Oxford: Pergamon Press, 1967:foreword, 7
15. Knox EG. Cervical cytology: a scrutiny of the evidence. In McLachlan G, ed. Problems and progress in medical care, essays on current research. 2nd series. London: Oxford University Press, 1966:277-307.
16. Franks LM. Cytology service and the ministry [letter to editor]. BMJ 1967:498.
17. Ahluwalia HS, Doll R. Mortality from cancer of the cervix uteri in British Columbia and other parts of Canada. Br J Prev Soc Med 1968;22:161-4.
18. Kinlen LJ, Doll R. Trends in mortality from cancer of the uterus in Canada and in England and Wales. Br J Prev Soc Med 1973;27:146-9.
19. Martin PL. How preventable is invasive cervical cancer? A community study of preventable factors. Commentary, Dr Robert Goodlin. Am J Obstet Gynecol 1972;113:541-8.
20. Editorial. Uncertainties of cervical cytology. BMJ 1973;4:501-2.
21. Kolstad P, Klem V. Long-term follow-up of 1121 cases of carcinoma in situ. Obstet Gynecol 1976;48:125-9.
22. Paterson MEL, Peel KR, Joslin CAF. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire. BMJ Clin Res 1984;289:896-8.
23. Recommendations on cervical screening. BMJ 1986;293:970.
24. Richart R. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynaecol 1967;10:748-54.
25. Stafl A, Wilkinson EJ. Cervical and vaginal intra-epithelial neoplasia. In: Stallworthy J, Bourne G, eds. Recent advances in obstetrics and gynaecology. Edinburgh: Churchill Livingstone, 1979:268.
26. Editorial. Cervical epithelial dysplasia. BMJ 1975;1:294-5.
27. Singer A. Cervical epithelial dysplasia. BMJ 1975;1:169-80.
28. Bogdanich W. Lax laboratories: The Pap test misses much cervical cancer through lab's errors-cut-rate ' Pap mills' process slides using screeners with incentives to rush-misplaced sense of security? Wall Street Journal 2 November 1987:1-6.
29. Cancer of the cervix: death by incompetence [editorial]. Lancet 1985:2:363-4.
30. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987;1:1247-9.
31. Skrabanek P. Cervical cancer screening. Lancet 1987;ii;1432.
32. Skrabanek P. Cervical cancer screening. Lancet 1987;ii:510.
33. Day NE, Hakama M. Screening for cervical cancer. Lancet 1987;ii:210-860.
34. Murphy MFG, Campbell MJ, Goldblatt PO. Twenty years' screening for cancer: the uterine cervix in Great Britain, 1964-84; further evidence of its ineffectiveness. J Epidemiol Community Health 1988;42:49-53.
35. Williams C. Ovarian and cervical cancer (current issues in cancer). BMJ 1992;304:1501-4.
36. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
37. Posner T. What's in a smear? Cervical screening, medical signs and metaphors. Sei Cult 1991;2:166-87.
38. Posner T, Vessey M. Prevention of cervical cancer: the patient's view. London: King Edward's Hospital Fund for London, 1988:44.
39. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
40. Saffron L. Cervical cancer: the politics of prevention. Spare Rib 1983;129:47.
41. Skrabanek P, McCormick J. Follies and fallacies in medicine. Glasgow: The Tarragon Press, 1989:104.
42. Foster P. Women and the health care industry: an unhealthy relationship? Buckingham: Open University Press, 1995:116.
43. Outcome of pregnancy after cone biopsy. BMJ 1980:280:1393-4.
44. McCormick JS. Cervical smears: a questionable practice? Lancet 1989;2:207-9.
45. Raffle AE, Alden B, Mackenzie EFD. Detection rates for abnormal cervical smears: what are we screening for? Lancet 1995;345:1469- 73.
46. Raffle AE, Alden B, Quinn M, et al. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003;326:901-4.
47. Bonneux L. Harms and benefits of screening to prevent cervical cancer [letter]. Lancet 2004;364:1483.
48. Raffle AE. New tests in cervical screening. Lancet 1998;351:297.
49. Greer G. The whole woman. New York: Alfred A Knopf, 1999:123.
50. Green GH. Letter to the editor. NZ Med J 1985;98:968.